Invesco Ltd. Omega Therapeutics, Inc. Transaction History

Invesco Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.73 - $5.32 $303 - $590	-111 Reduced 1.03%	10,708 $39,000
Q4 2023 Feb 12, 2024	SELL	$1.35 - $3.21 $3,446 - $8,195	-2,553 Reduced 19.09%	10,819 $32,000
Q3 2023 Nov 13, 2023	BUY	$2.15 - $5.68 $90 - $238	42 Added 0.32%	13,372 $28,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $74,648 - $128,767	13,330 New	13,330 $74,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $27.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.